CBS 2019
CBSMD教育中心
中 文

Acute Coronary Syndrom

Abstract

Recommended Article

From Early Pharmacology to Recent Pharmacology Interventions in Acute Coronary Syndromes Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI) Aggressive lipid-lowering therapy after percutaneous coronary intervention – for whom and how? Prevalence of Angina Among Primary Care Patients With Coronary Artery Disease Acute Myocardial Infarction Transition of Macrophages to Fibroblast-Like Cells in Healing Myocardial Infarction Interval From Initiation of Prasugrel to Coronary Angiography in Patients With Non–ST-Segment Elevation Myocardial Infarction

ConsensusApril 2020

JOURNAL:JACC Article Link

Management of Acute Myocardial Infarction During the COVID-19 Pandemic

E Mahmud, HL Dauerman, FGP Welt et al. Keywords: emergency medical system; COVID-19; fibrinolysis; PCI; STEMI

Full Text PDF